UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000006556 |
|---|---|
| Receipt number | R000007769 |
| Scientific Title | Adjunctive treatment with pramipexole for antipsychotic-induced hyperprolactinemia in patients with schizophrenia, Reserch for efficacy and tolerability. |
| Date of disclosure of the study information | 2011/10/20 |
| Last modified on | 2014/08/25 09:41:32 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Adjunctive treatment with pramipexole for antipsychotic-induced hyperprolactinemia in patients with schizophrenia, Reserch for efficacy and tolerability.
Acronym
Adjunctive treatment with pramipexole for antipsychotic-induced hyperprolactinemia.
Scientific Title
Adjunctive treatment with pramipexole for antipsychotic-induced hyperprolactinemia in patients with schizophrenia, Reserch for efficacy and tolerability.
Scientific Title:Acronym
Adjunctive treatment with pramipexole for antipsychotic-induced hyperprolactinemia.
Region
| Japan |
Condition
Condition
schizophrenia
Classification by specialty
| Psychiatry |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the efficacy and tolerability of pramipexole in the treatment of antipsychotics-induced hyperprolactinemia.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
serum prolactin level, Udvalg for Kliniske Undersogelser (UKU) Side Effect Rating Scale
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
pramipexole
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 50 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
schizophrenic patients who developed symptomatic hyperprolactinemia while taking antipsychotics
Key exclusion criteria
subjects were excluded if they had problems with thyroid function, renal function,liver function, gynecological problems, or other general illnesses.
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Ishitobi Makoto |
Organization
University of Fukui
Division name
Department of Neuropsychiatry
Zip code
Address
23-3 Matsuokashimoaizuki,Eiheiji-Cho, Yoshida-Gun, Fukui 910-1193, Japan
TEL
0776-61-3111
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name |
Organization
University of Fukui
Division name
Department of Neuropsychiatry
Zip code
Address
23-3 Matsuokashimoaizuki,Eiheiji-Cho, Yoshida-Gun, Fukui 910-1193, Japan
TEL
Homepage URL
Sponsor or person
Institute
Department of Neuropsychiatry,University of Fukui
Institute
Department
Personal name
Funding Source
Organization
Scientific Research from the Japan Society for the Promotion of Science.
Organization
Division
Category of Funding Organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2011 | Year | 10 | Month | 20 | Day |
Related information
URL releasing protocol
Publication of results
Partially published
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2011 | Year | 08 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2011 | Year | 11 | Month | 01 | Day |
Last follow-up date
| 2013 | Year | 03 | Month | 01 | Day |
Date of closure to data entry
| 2013 | Year | 03 | Month | 01 | Day |
Date trial data considered complete
| 2013 | Year | 03 | Month | 01 | Day |
Date analysis concluded
| 2013 | Year | 03 | Month | 01 | Day |
Other
Other related information
Management information
Registered date
| 2011 | Year | 10 | Month | 17 | Day |
Last modified on
| 2014 | Year | 08 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007769
